RxDoctor Payments Data

Robin Abel

Gerontology · Birmingham, ALNPI 1528360534

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 32 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 15.8% — the pattern of someone who eats at a lot of different presentations.

$3,248in general payments, 2019–2025

Across 32 payments — averaging $101.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Acadia Pharmaceuticals Inc$514
  • Neurocrine Biosciences, Inc.$337
  • Axsome Therapeutics, Inc.$264
  • AstraZeneca$254
  • Teva Pharmaceuticals USA, Inc.$248
  • AbbVie$243
  • plus $1K from 12 others

What the payments were for

  • Food & beverage$3,248100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,248 in reported general payments places this provider in the 80th percentile of 143 gerontology providers in Alabama.

See all gerontology providers in Alabama

Medicare billing

Part B allowed, 2024
$106,226
Medicare patients
166
Services billed
1,840

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban19$13,346
Lantus SolostarInsulin Glargine,hum.Rec.Anlog12$822
Atorvastatin Calcium41$783
Insulin Glargine-Yfgn12$624
Duloxetine Hcl14$516
Potassium Chloride42$412
Ipratropium-AlbuterolIpratropium/Albuterol Sulfate15$407
Mirtazapine11$378
Furosemide51$295
Ropinirole Hcl13$276
Amlodipine Besylate30$265
Donepezil Hcl25$249
Fluticasone Propionate12$237
Simvastatin21$230
Metoprolol Succinate18$228

Paid to pharmacies, not to this prescriber.

Other gerontology in Birmingham

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →